We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-7.72%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$157M
AUM Growth
+$31.7M
Cap. Flow
+$45.5M
Cap. Flow %
28.95%
Top 10 Hldgs %
45.06%
Holding
108
New
39
Increased
16
Reduced
23
Closed
22

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$8.9M
2
MA icon
Mastercard
MA
+$8.7M
3
FISV
Fiserv Inc
FISV
+$8.43M
4
PYPL icon
PayPal
PYPL
+$6.75M
5
FIS icon
Fidelity National Information Services
FIS
+$4.01M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$5.13M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$4.35M
3
NUAN
Nuance Communications, Inc.
NUAN
+$3.59M
4
CONE
CyrusOne Inc Common Stock
CONE
+$3.47M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$1.99M

Sector Composition

Rank Sector Weight
1 Healthcare 44.39%
2 Technology 25.46%
3 Financials 19.54%
4 Consumer Discretionary 2.88%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DELL icon
1
Dell
DELL
$262B
$17.8M 11.34%
355,444
– –
V icon
2
Visa
V
$683B
$9.12M 5.8%
+41,135
New +$8.9M
MA icon
3
Mastercard
MA
$506B
$8.65M 5.5%
+24,204
New +$8.7M
FISV
4
Fiserv Inc
FISV
$28.7B
$8.45M 5.37%
+83,286
New +$8.43M
PYPL icon
5
PayPal
PYPL
$48.9B
$5.87M 3.73%
+50,718
New +$6.75M
MSDAU
6
DELISTED
MSD Acquisition Corp. Unit
MSDAU
$4.94M 3.14%
500,000
– –
CPNG icon
7
Coupang
CPNG
$29.3B
$4.53M 2.88%
256,264
– –
PBCT
8
DELISTED
People's United Financial Inc
PBCT
$3.92M 2.49%
196,100
– –
FIS icon
9
Fidelity National Information Services
FIS
$23.2B
$3.85M 2.45%
+38,303
New +$4.01M
COHR
10
DELISTED
Coherent Inc
COHR
$3.72M 2.36%
13,600
– –
CHNG
11
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$3.53M 2.25%
162,100
– –
CERN
12
DELISTED
Cerner Corp
CERN
$3.49M 2.22%
+37,300
New +$3.45M
ATVI
13
DELISTED
Activision Blizzard
ATVI
$3.2M 2.04%
+40,000
New +$3.12M
FHN icon
14
First Horizon
FHN
$12.2B
$3.18M 2.02%
+135,400
New +$2.7M
CTXS
15
DELISTED
Citrix Systems Inc
CTXS
$3.17M 2.01%
+31,400
New +$3.17M
ACRS icon
16
Aclaris Therapeutics
ACRS
$732M
$2.73M 1.73%
158,243
+46,083
+41% +$629K
FATE icon
17
Fate Therapeutics
FATE
$286M
$2.51M 1.59%
64,665
+41,584
+180% +$1.61M
CYTK icon
18
Cytokinetics
CYTK
$10.6B
$2.42M 1.54%
65,769
+30,537
+87% +$1.09M
KURA icon
19
Kura Oncology
KURA
$796M
$2.38M 1.51%
147,833
+65,709
+80% +$949K
PTGX icon
20
Protagonist Therapeutics
PTGX
$8.76B
$2.18M 1.39%
92,045
+61,046
+197% +$1.72M
RLAY icon
21
Relay Therapeutics
RLAY
$4.13B
$2.05M 1.31%
68,608
+22,616
+49% +$549K
RPTX
22
DELISTED
Repare Therapeutics
RPTX
$2.04M 1.3%
143,375
+99,878
+230% +$1.48M
CPARU
23
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
$2.02M 1.28%
200,000
– –
APLS
24
DELISTED
Apellis Pharmaceuticals
APLS
$1.88M 1.19%
+36,893
New +$1.63M
GBT
25
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.77M 1.13%
+51,085
New +$1.53M
1
2 3 4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return

HighVista Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, HighVista Strategies held 108 positions worth $157M, up 25% from $126M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

HighVista Strategies deployed $45.5M of net new capital in Q1 2022, opening 39 new positions and adding to 16 existing holdings. Its largest new stake was Visa: 41,135 shares worth $9.12M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 53% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Xenon Pharmaceuticals, an estimated $1.05M trimmed.

  • HighVista Strategies's largest Q1 2022 buy was Visa: 41,135 shares worth $9.12M.
  • HighVista Strategies added most to Protagonist Therapeutics in Q1 2022, an estimated $1.72M increase.
  • HighVista Strategies's biggest Q1 2022 reduction was Xenon Pharmaceuticals, cutting an estimated $1.05M.
  • HighVista Strategies fully exited Xilinx Inc in Q1 2022, selling an estimated $5.13M.
  • HighVista Strategies's ten largest holdings make up 45% of its $157M portfolio in Q1 2022.
  • HighVista Strategies opened 39 new positions and closed 22 in Q1 2022.
  • HighVista Strategies's portfolio value rose 25% quarter-over-quarter to $157M.

Based on HighVista Strategies's 13F filing for Q1 2022, filed 16 May 2022.